675583-73-0

Upstream product

• 104750-60-9 2-bromo-1-(methoxymethoxy)-4-methylbenzene 
• 854779-34-3 4-(tert-butyl-diphenyl-silanyloxymethyl)-1-(2-methoxymethoxy-5-methyl-phenyl)-1H-imidazole 
• 854779-50-3 [1-(2-methoxymethoxy-5-methyl-phenyl)-1H-imidazol-4-yl]-methanol 
• 675583-72-9 1-(2-methoxymethoxy-5-methyl-phenyl)-1H-imidazole-4-carbaldehyde 
• 478685-71-1 2-(methoxymethoxy)-5-methylbenzeneboronic acid 

Downstream Products

• 675583-74-1 6-{[[1-(2-methoxymethoxy-5-methyl-phenyl)-1H-imidazol-4-ylmethyl]-(1-methyl-1H-imidazol-2-ylmethyl)-amino]-methyl}-nicotinic acid 
• 854779-53-6 6-{[[1-(2-methoxymethoxy-5-methyl-phenyl)-1H-imidazol-4-ylmethyl]-(1-methyl-1H-imidazol-2-ylmethyl)-amino]-methyl}-nicotinic acid methyl ester 

Relevant academic research and scientific papers

Formation and spectroscopic characterization of the dioxygen adduct of a heme-Cu complex possessing a cross-linked tyrosine-histidine mimic: modeling the active site of cytochrome c oxidase.

A binucleating porphyrin with covalently appended copper chelates having a cross-linked imidazole-phenol group as the novel active site model of cytochrome c oxidase has been prepared, and the dioxygen adduct of its iron(II)-copper(I) complex was spectros